Simplex Trading
TVRD

Simplex Trading’s Tvardi Therapeutics TVRD Stock Holding History

Simplex Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$7K – 10478
2025
Q3 		$7K Buy
+200
New +$5.69K ﹤0.01% 8148
2025
Q1 		– Sell
-133
Closed -$2K – 9947
2024
Q4 		$2K Buy
+133
New +$1.45K ﹤0.01% 8116
2023
Q1 		– Sell
-225
Closed -$86K – 10349
2022
Q4 		$86K Buy
225
+44
+24% +$16.7K ﹤0.01% 5265
2022
Q3 		$60K Buy
181
+37
+26% +$13.4K ﹤0.01% 6199
2022
Q2 		$47K Sell
144
-23
-14% -$8.07K ﹤0.01% 6598
2022
Q1 		$72K Sell
167
-61
-27% -$25K ﹤0.01% 6626
2021
Q4 		$99K Buy
228
+86
+61% +$43.2K ﹤0.01% 6267
2021
Q3 		$73K Buy
142
+3
+2% +$1.5K ﹤0.01% 7048
2021
Q2 		$71K Buy
139
+131
+1,638% +$83K ﹤0.01% 7201
2021
Q1 		$605K Buy
8
+6
+300% +$4.11K ﹤0.01% 3099
2020
Q4 		$92K Hold
2
– – ﹤0.01% 5527
2020
Q3 		$90K Sell
2
-4
-67% -$2.32K ﹤0.01% 5025
2020
Q2 		$338K Sell
6
-2
-25% -$1.1K ﹤0.01% 3384
2020
Q1 		$359K Buy
8
+1
+14% +$543 ﹤0.01% 2949
2019
Q4 		$389K Buy
7
+1
+17% +$702 ﹤0.01% 3002
2019
Q3 		$424K Sell
6
-2
-25% -$1.66K ﹤0.01% 2780
2019
Q2 		$645K Buy
8
+2
+33% +$1.41K ﹤0.01% 2341
2019
Q1 		$400K Buy
6
+3
+100% +$1.8K ﹤0.01% 2890
2018
Q4 		$156K Sell
3
-1
-25% -$645 ﹤0.01% 3414
2018
Q3 		$349K Sell
4
-17
-81% -$12.3K ﹤0.01% 3003
2018
Q2 		$1.46M Buy
21
+19
+950% +$9.66K 0.01% 1417
2018
Q1 		$13K Sell
2
-6
-75% -$2.91K ﹤0.01% 3813
2017
Q4 		$73K Buy
8
+3
+60% +$1.37K ﹤0.01% 2080
2017
Q3 		$37K Sell
5
-37
-88% -$18.5K ﹤0.01% 2581
2017
Q2 		$272K Buy
42
+24
+133% +$15.2K 0.01% 1006
2017
Q1 		$55K Buy
18
+16
+800% +$8.55K ﹤0.01% 2270
2016
Q4 		$5K Hold
2
– – ﹤0.01% 4411
2016
Q3 		$3K Buy
2
+1
+100% +$217 ﹤0.01% 4757
2016
Q2 		$3K Sell
1
-2
-67% -$435 ﹤0.01% 4726
2016
Q1 		$2K Buy
+3
New +$896 ﹤0.01% 4842
2015
Q4 		– Hold
0
– -$3K – 6278
2015
Q3 		– Sell
-1
Closed -$669 – 4442
2015
Q2 		$1K Buy
+1
New +$386 ﹤0.01% 4835

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $361M AUM 18% 1-Year Est. Return

Simplex Trading's TVRD Position: Q1 2026 in Review

Simplex Trading sold out of Tvardi Therapeutics (TVRD) in Q1 2026, closing a stake of 1,418 shares — an estimated $6.1K sold.

Simplex Trading first reported a position in TVRD in Q1 2016 and held it in 31 quarters. The position peaked at $447K in Q3 2018. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Simplex Trading reported no remaining Tvardi Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,418 Tvardi Therapeutics shares in Q1 2026, an estimated $6.1K.
  • Simplex Trading first reported a position in Tvardi Therapeutics in Q1 2016 and held it in 31 quarters.
  • Simplex Trading's Tvardi Therapeutics position peaked at $447K in Q3 2018.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.